P

Porton Pharma Solutions Ltd
SZSE:300363

Watchlist Manager
Porton Pharma Solutions Ltd
SZSE:300363
Watchlist
Price: 23.42 CNY 1.25% Market Closed
Market Cap: 12.7B CNY

Wall Street
Price Targets

Price Targets Summary
Porton Pharma Solutions Ltd

Wall Street analysts forecast Porton Pharma Solutions Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Porton Pharma Solutions Ltd is 30.6 CNY with a low forecast of 30.3 CNY and a high forecast of 31.5 CNY.

Lowest
Price Target
30.3 CNY
29% Upside
Average
Price Target
30.6 CNY
31% Upside
Highest
Price Target
31.5 CNY
35% Upside
Porton Pharma Solutions Ltd Competitors:
Price Targets
WVE
WAVE Life Sciences Ltd
172% Upside
POLB
Poolbeg Pharma PLC
431% Upside
HIKAL
Hikal Ltd
27% Upside
APLLTD
Alembic Pharmaceuticals Ltd
17% Upside
867
China Medical System Holdings Ltd
25% Upside
HYPE3
Hypera SA
19% Upside
IPN
Ipsen SA
8% Upside
MDWD
Mediwound Ltd
82% Upside

Revenue
Forecast

Revenue Estimate
Porton Pharma Solutions Ltd

For the last 13 years the compound annual growth rate for Porton Pharma Solutions Ltd's revenue is 14%. The projected CAGR for the next 3 years is 17%.

14%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Porton Pharma Solutions Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Porton Pharma Solutions Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Porton Pharma Solutions Ltd's stock price target?
Price Target
30.6 CNY

According to Wall Street analysts, the average 1-year price target for Porton Pharma Solutions Ltd is 30.6 CNY with a low forecast of 30.3 CNY and a high forecast of 31.5 CNY.

What is Porton Pharma Solutions Ltd's Revenue forecast?
Projected CAGR
17%

For the last 13 years the compound annual growth rate for Porton Pharma Solutions Ltd's revenue is 14%. The projected CAGR for the next 3 years is 17%.

Back to Top